A small trial found an Indian-made primaquine matches the reference malaria drug
In short: Malaria elimination needs more quality-assured medicines. A bioequivalence trial compared a tablet made by Ipca Laboratories with the Sanofi reference primaquine in healthy volunteers. The two behaved very similarly in the body, which opens a route toward prequalification and wider use in malaria-endemic countries.
Primaquine is one of the few drugs able to clear the dormant liver forms of malaria parasites, which is why it matters for efforts to eliminate the disease. The source notes that only one 15 mg primaquine tablet had been registered by a stringent regulatory authority and marketed, so more quality-assured versions were needed.
The study was a two-sequence crossover trial with a 10-day washout. Healthy volunteers aged 18 to 45 took either the test tablet or the reference tablet on an empty stomach with water, and blood samples were drawn over 72 hours. Of 50 volunteers, 47 completed both rounds and were analysed. Researchers measured the peak concentration and total drug exposure, and judged bioequivalence by whether the 90% confidence intervals fell within 80 to 125 per cent.
The results fell inside that range for both measures. For peak concentration the geometric mean ratio was 104.17 per cent, with a 90% interval of 96.92 to 111.96 per cent. For total exposure the ratio was 105.76 per cent, with an interval of 99.76 to 112.08 per cent. Clearance, volume of distribution and half-life were also similar, with a median half-life of 5.2 hours for both products.
The authors conclude that the Ipca primaquine is bioequivalent to the Sanofi product, and they suggest this supports prequalification, registration in endemic countries and programmatic use. This is a single bioequivalence study in healthy adults, so it shows the tablets behave alike in the body rather than proving clinical outcomes in patients.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination.
- Also: Ipca Laboratories
To cite this card, link to https://intellectplus.co.uk/app/health-ipca-laboratories.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health, medicine and disease · More in Health · Latest · A–Z · All topics